Cargando…
Midnolin is a confirmed genetic risk factor for Parkinson’s disease
OBJECTIVE: Genetic analysis of patients with familial Parkinson’s disease (PD) identified many causative genes. However, the majority of PD cases are sporadic, and the mechanisms of onset still remain unclear. Previously, we found that Midnolin (MIDN) is associated with PD in a Yamagata (Japan) coho...
Autores principales: | Obara, Yutaro, Sato, Hidenori, Nakayama, Takahiro, Kato, Takeo, Ishii, Kuniaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856597/ https://www.ncbi.nlm.nih.gov/pubmed/31588691 http://dx.doi.org/10.1002/acn3.50914 |
Ejemplares similares
-
Midnolin is a novel regulator of parkin expression and is associated with Parkinson’s Disease
por: Obara, Yutaro, et al.
Publicado: (2017) -
Reply to: MIDN locus structural variants and Parkinson’s disease risk
por: Obara, Yutaro, et al.
Publicado: (2020) -
Midnolin Regulates Liver Cancer Cell Growth In Vitro and In Vivo
por: Kweon, Soo-Mi, et al.
Publicado: (2022) -
The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation
por: Gu, Xin, et al.
Publicado: (2023) -
A genetic risk factor for idiopathic normal pressure hydrocephalus (iNPH).
por: Kato, Takeo, et al.
Publicado: (2015)